Research article summary (published 30 Aug 2009):

Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Di Maio, Massimo (M); Daniele, Bruno (B); Perrone, Francesco (F);

Affiliation: Clinical Trials Unit, National Cancer Institute-G.Pascale Foundation, Napoli, Italy. dimaiomax(-atsign-)libero.it

Journal and publication information

Publication Type: Journal Article

Journal: Nature reviews. Clinical oncology (Nat Rev Clin Oncol), published in England. (Language: eng)

Reference: 2009-Sep; vol 6 (issue 9) : pp 505-6

Dates: Created 2009/08/26; Completed 2009/11/04;

PMID: 19707242, status: MEDLINE (last retrieval date: 11/4/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Antineoplastic Agents - therapeutic use Benzenesulfonates - therapeutic use Carcinoma, Hepatocellular - pathology; therapy Clinical Trials, Phase III as Topic Fibrosis - pathology Humans

Liver Neoplasms - pathology; therapy Practice Guidelines as Topic Pyridines - therapeutic use Randomized Controlled Trials as Topic Survival Analysis Time Factors

Associated Chemicals: Antineoplastic Agents (0) ; Benzenesulfonates (0) ; Pyridines (0) ; sorafenib (0)

Related articles

These are the highest related articles currently in the database:

• Novel advancements in the management of hepatocellular carcinoma in 2008. 10 Feb 2008
• [The hepatocellular carcinoma: alternative therapeutical strategies] 30 Jul 2007
• Sorafenib in hepatocellular carcinoma: separating the hype from the hope. 22 Nov 2008
• Phase II trial of sorafenib in advanced thyroid cancer. 7 Jun 2008
• Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach? 30 Jul 2007
• Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment. 29 Nov 2005
• Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. 29 Nov 2007
• Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. 11 Oct 2007
• Sorafenib, a systemic therapy for hepatocellular carcinoma. 30 Dec 2007
• FDA approves sorafenib for patients with inoperable liver cancer. 30 Jan 2008

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.